Target intelligence / Profile preview

Cingulin-like protein 1 (CGNL1)

Target
CGNL1
Molecular classification
Cytoskeletal protein, Junctional adaptor protein, Membrane-associated protein, Other
01

Overview

Cingulin-like protein 1 (CGNL1), also known as paracingulin, is a cytoskeletal junctional adaptor protein encoded by the CGNL1 gene and found predominantly at tight and adherens junctions in epithelial and endothelial cells. It plays a pivotal role in assembling and maintaining cell–cell junctions by regulating activities of small GTPases (notably RhoA and Rac1), which are essential for organizing the actin cytoskeleton and preserving epithelial barrier function. CGNL1's structural domains include a globular head, a central coiled-coil rod, and a tail; it can form dimers and interacts with proteins such as ZO-1 and PLEKHA7, enabling localized modulation of cytoskeletal elements and junctional stability. In endothelium, CGNL1 is important for focal adhesion formation, vinculin and paxillin recruitment, and angiogenesis by stabilizing VE-cadherin interactions. While rearrangements of the CGNL1 promoter can cause aromatase excess syndrome, CGNL1 is not considered a therapeutic target nor are there drugs known to interact with it. The gene is conserved across vertebrates, with functions primarily in cell junction dynamics and cytoskeletal regulation.

Other names
ParacingulinJACOPJunction-associated coiled-coil proteinPCINGKIAA1749FLJ14957cingulin-like protein 1junction-associated coiled-coil proteinparacingulin
02

Biological functions

Junction assembly and maintenanceRegulation of Rho GTPases (RhoA, Rac1)Organization of actin cytoskeletonCell–cell adhesionRegulation of barrier functionRegulation of angiogenesis, vascular stability
03

Disease associations

Aromatase excess syndrome (in cases of chromosomal rearrangement involving its promoter)Pseudo-Torch syndrome 1 (clinical association)Roles in endothelial function, but direct implication in major disease such as cancer, inflammation, neurodegeneration, or cardiovascular disease is not established

Beyond the preview

Go deeper on Cingulin-like protein 1 (CGNL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cingulin-like protein 1 (CGNL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call